DaVita (DVA)
(Delayed Data from NYSE)
$148.88 USD
+3.04 (2.08%)
Updated Aug 14, 2024 04:00 PM ET
After-Market: $148.76 -0.12 (-0.08%) 6:26 PM ET
1-Strong Buy of 5 1
A Value C Growth B Momentum A VGM
Brokerage Reports
DaVita Inc. [DVA]
Reports for Purchase
Showing records 201 - 220 ( 289 total )
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
4Q Results and Call Highlight Longer-Term Growth Uncertainties
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Downgrading on Valuation/Slightly Lower Growth Outlook
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Discontinuation of Research Coverage
Provider: FELTL & COMPANY
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Solid Kidney Care results overshadowed by weak HCP performance
Provider: FELTL & COMPANY
Analyst: WEIGHT M
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Reducing Estimates Slightly as HCP Continues to Stumble
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J